U.S. listed company Sonnet will merge to form Hyperliquid Strategies and launch a Treasury Reserve Strategy holding 12.6 million HYPE tokens and $3 billion in cash.
BlockBeats News, July 14th, according to The Block, Nasdaq-listed company Sonnet BioTherapeutics has agreed to an $8.88 billion merger deal, will be renamed Hyperliquid Strategies, and will launch the HYPE treasury strategy.
The Nasdaq-listed company Sonnet BioTherapeutics has agreed to merge with Rorschach I LLC to form Hyperliquid Strategies and launch a treasury strategy. According to a press release issued on Monday, Rorschach I LLC is a newly formed company by affiliated entities of Atlas Merchant Capital LLC, companies affiliated with Paradigm Operations LP, and other sponsors.
Upon completion of the transaction, the new entity will be renamed Hyperliquid Strategies and is expected to hold 12.6 million HYPE tokens and $305 million in cash, with an estimated total valuation of approximately $8.88 billion. The transaction has attracted strategic investors such as Paradigm, Galaxy Digital, Pantera Capital, D1 Capital, Republic Digital, and 683 Capital. After the merger, Hyperliquid Strategies will continue to trade on Nasdaq, with a change in stock symbol, becoming a publicly traded cryptocurrency treasury company.
The parties to the transaction stated that the cash proceeds will enable Hyperliquid Strategies to increase its holdings of HYPE tokens to build a premier HYPE strategic reserve. Upon completion of the transaction, Atlas Co-founder and CEO Bob Diamond will serve as Chairman of Hyperliquid Strategies, and another Atlas Co-founder and CIO David Schamis will serve as CEO.
You may also like

BIS's latest research: The future of stablecoins and the global monetary landscape

Morning News | Michael Saylor releases Bitcoin Tracker information; Aave releases post-attack investigation on Kelp rsETH bridge; Gravity Bridge announces service suspension after being attacked

Three years later: Looking back at my judgment of ChatGPT in 2023

From Casino Tools to Global Pricing Machines: The NYSE Leader's Perspective on Hyperliquid

A Detailed Analysis of "Stock God Serenity" Investment Methodology

Sharplink CEO: The future of Ethereum is unfolding

Morning Report | Korea Investment & Securities and OKX plan to jointly acquire 40% of Coinone; Polymarket denies implementing KYC comprehensively; Grayscale delays U.S. stock IPO plans

Bit Digital CEO: Why I Bought More ETH

A Decade of Three Waves of Stock Tokenization from Bitget's Reality: An Unfinished Financial Exploration

"Hu Run Baifu" Dialogue with Sun Yuchen: A New Paradigm of Value Circulation in the Web3 Transformation Cycle

Is it hackers and regulation that ruined DeFi?

Chris Lee: From crypto OG to heavy investments in the three storage giants, predictions on AI bull market corrections, Web4, and opportunities for the younger generation

Ready for a Walk on the Wilder Side of Proof of Talk 2026? Join WEEX Labs in Paris

Gold vs Bitcoin in 2026: Which Market Is Giving Traders Better Opportunities?

Morning News | Coinbase partners with Standard Chartered Bank to expand multi-currency fiat channels; Sharplink and Forward will be included in the Russell Index; JPMorgan may issue stablecoins in the future

Hash Global Founder: Why I Also Chose to Liquidate All My ETH?

Tokenized US Stock Duel: Ondo vs. xStocks, Who is Defining On-Chain Nasdaq?

